Organon

Creating a brighter future for her takes the commitment and passion of our team from around the globe. In 2023, we accelerated progress in innovating for women’s health, helped prevent unplanned pregnancies, advanced gender equity, reduced our carbon footprint and more. Read about our progress ?? https://ogn.llc/6046mxgin #ESGReport #WomensHealth #Sustainability #SocialImpact

Even in female-dominated industries, gender bias persists. Working mothers face stigmas that can make it challenging for them to advance in their careers and can contribute to broader gender inequalities in the workplace, according to the Harvard Business Review and Washington University in St. Louis. Traditional barriers and stereotyping may add to potential challenges. Listen as Organon Egypt’s Gina Zaki discusses the stigma she encountered as a woman wanting to start a family and pursue the career of her dreams. She faced doubt from others and constant pressure to align with cultural norms, being told to take a job less demanding, but Gina persisted. This is her story – a reminder of the importance of gender equity for women everywhere. #GlobalDiversityAwarenessMonth

A recent survey found that 56% of Gen Z use TikTok for advice on wellness, and 1 in 3 don’t double-check or verify the information that they get via TikTok. With the growing mis- and disinformation on reproductive health, including birth control, young women may be more influenced by what they see online than evidence-based information from medical sources like a healthcare professional.? What’s at stake? That is a question Dr. Charlotte Owens, MD, FACOG, Head of Medical Affairs & Outcomes Research at Organon and a board-certified OB/GYN, answers. Read more: https://ogn.llc/6001mQS8V #ThxBirthControl #ReproductiveHealth #WomensHealth #Contraception

In our diverse world, embracing our differences is key. Every unique perspective and experience help enhance our collective understanding and fuels innovation. And, when we embrace diversity, we help foster a culture of inclusion and empathy. Listen as Organon’s Tejal Shah discusses how she shares her unique heritage, as well as seeks to learn about others, through her involvement in Organon’s Employee Resource Groups. #GlobalDiversityAwarenessMonth

In the latest issue of Fortune Italia, Organon CEO Kevin Ali discusses our efforts in R&D and focusing on potential solutions for the health of a woman, as well as enabling demographic resilience. This means adapting to demographic changes related to unintended pregnancies, falling birth rates and aging populations to maintain social, economic, and environmental stability. Watch to hear Kevin speak about how the power of public-private partnerships is crucial to creating a sustainable future. #DemographicResilience #FamilyPlanning #PublicPrivatePartnerships

In 2024, it is estimated that there will be 310,720 new cases of female breast cancer, according to the National Cancer Institute. According to the American Cancer Society, most of these women will receive treatment and survive for many years. Supporting a breast cancer patient throughout their journey includes a team of healthcare professionals working together to ensure a patient’s needs are met – from physical to emotional – no matter where they are in their journey. Today, we are recognizing the survivors, forever fighters, and their care teams that make all the difference. To all the doctors, nurses, nurse practitioners, administrators, physician assistants, pharmacists, staff, case managers, nurse navigators, and others, thank you for everything you do each and every day. #BreastCancerAwarenessMonth #BreastCancerAwareness

#Migraines – a potentially debilitating condition that affects ~1 billion people globally – are more than just headaches; they may cause severe pain, nausea, and sensitivity to light and sound, potentially impacting daily life. Although men and women can experience migraines, women are three times as likely as men to experience them. If you or someone you know suffers from migraines, remember you're not alone. At Organon, we’re committed to supporting those with migraine by improving access to treatment options and helping reduce the stigma associated with this condition. #PainAwarenessMonth #MigraineAwareness #Migraine #ChronicPain

Today, we announced with Shanghai Henlius Biotech that the phase 3 comparative clinical trial for an investigational #biosimilar met its primary endpoint. Read the #news here: https://ogn.llc/6047mYtSb

High cholesterol often shows no symptoms. It can quietly build up and increase your risk of cardiovascular disease (CVD)—the leading cause of death—that often goes underdiagnosed and undertreated in women. Don’t miss these red flags when it comes to your health, so you can manage cholesterol levels and help reduce your risk of CVD. #WorldHeartDay #CholesterolEducationMonth

In the U.S., despite a large increase in the number of #biosimilars available, uptake has been slower than expected. Savings from biosimilars have more than tripled from 2019 to 2020 to nearly $8 billion. Organon is committed to making a difference by supporting the adoption of biosimilars across the health care system, so patients have better access to potentially more affordable treatments. Learn more at: https://ogn.llc/6045mgMoc